Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

Subjects

Subjects :

Humans
Cyclophosphamide therapeutic use
Chronic Disease
Recurrence
Mutation
Retrospective Studies
Hematopoietic Stem Cell Transplantation
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute therapy
Graft vs Host Disease

Details

Language :

English

ISSN :

1476-5365

Volume :

59

Issue :

3

Database :

MEDLINE

Journal :

Bone marrow transplantation

Publication Type :

Editorial & Opinion

Accession number :

38182672

Full Text :

https://doi.org/10.1038/s41409-023-02189-9